Progressive Care Inc (fka RXMD)

[Jimmy Quick]

$RXMD $18M Acquisition News Previously Released
REAL COMPANY - OTCQB – Penny Stock Exempt, 3 YEARS AUDITED FINANCIALS, Over 20 MILLION NET ANNUAL REVS for 2018 and now over 40 MILLION NET REVENUES with acquisition– HUGE LONGTERM INVESTMENT POTENTIAL. Doubled in Revenues, scripts, and assets with 1 deal.

OH MY, HOW RXMD HAS GROWN UP OVER THE YEARS


RXMD Revenues and Scripts per location, Second to None

What's happening for RXMD?

11 things specifically come to mind, and they keep generating more "Game Changers" by the week.

1. $18 Million Annual Revenue Purchase of Florida Base Pharmacy (SEE PRESS RELEASE dated 3/12/19 BELOW

Progressive Care Inc. Completes Acquisition of Family Physicians Rx

MIAMI – June 4, 2019 -- InvestorsHub NewsWire -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, announced today that it has closed on the acquisition of Family Physicians RX, Inc.,dba Five Star RX and Florida corporation (FSRX) on June 1, 2019.

The consummation of the acquisition allows for the Company to begin consolidating financial results from FSRX occurring after June 1st into disclosure reports and news releases. In the month prior to closing, FSRX filled approximately 18,000 prescriptions servicing 7,500 patients. With the addition of the Davie, FL and Orlando locations, Progressive Care now boasts 4 physical pharmacy locations with 5 star performance ratings and nearly 125 employees from which to launch further expansion and sales growth.

"This is our biggest accomplishment to date," said S. Parikh Mars, CEO of Progressive Care. "Now that FSRX is part of the Progressive Care family of pharmacies, we can focus on getting to next level as an organization. I am honored to have this group of talented individuals join our team and to take our collective strength to bring about change and results in this industry."


Acquisition Agreement

Progressive Care Inc. Executes Agreement to Purchase Florida Pharmacies

MIAMI March 12, 2019 Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, announced today the execution of a purchase agreement to acquire a Florida pharmacy with two locations.

On March 8, 2019, Progressive Care Inc. executed an agreement to purchase 100% of the stock in Family Physicians RX, Inc. aka Five Star RX, a Florida corporation (FPRX). FPRX has 2 locations in Florida: Davie and Orlando. FPRX has approximately $18 million in annual revenues and $500,000 in net income as of December 2018, the integration of which would yield $40 million in annual operating revenues for the Company.

2. Progressive Care Inc. Announces April Sales & Record Breaking Month

MIAMI – May 21, 2019 -- InvestorsHub NewsWire -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced further growth year-over-year in revenue and number of prescriptions filled for April 2019 and a record month for PharmCo revenue in Palm Beach, which increased at 100%.

In April, the company reported a total of $1.935 million in net revenue, a 17% increase from the same month last year, and a 30% increase in prescriptions filled during the same month last year, totaling nearly 28,725 prescriptions filled. Both PharmCo locations had 15% growth in prescription counts compared to April last year.

"Progressive Care's April sales and prescription numbers are directly attributed to increased sales derived from marketing activities promoting risk management, medication adherence management, and superior pharmacy performance metrics to Physicians Practices and Management Services Organizations," said S. Parikh Mars, Chief Executive Officer of Progressive Care Inc. "We are confident that our company will continue to grow with more record-breaking months by providing our customers with top-quality healthcare management services."

3. 2019 1st Quarter Conference Call to Discuss Results on May 15th - COMPLETE

Progressive Care Inc. Issues 1st Quarter 2019 Quarterly Report Conference Call Highlights

MIAMI, FL -- May 16, 2019 -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today issued 1st Quarter 2019 Quarterly Report Conference Call highlights.

The Company announced nearly $5.2 million in net revenues, a 3% increase over 2018. Revenues net nearly $275,000 in PBM fees charged during the quarter, which is an 89% increase over 2018. Prescriptions filled increased 28% to 84,500 during 1st quarter 2019. The company also filled over $1.9 million worth of prescriptions (Not Included in Net Revenues) for 340B entities during the quarter, generating fees to the pharmacy of
approximately $115,000 which is a 91% increase over the same period last year. The Company reported a net loss of approximately $750,000, which included nearly $300,000 of non-cash interest on notes payable and depreciation,$125,000 in increased PBM fees, inclusion of $120,000 of net losses from PharmCo 1002, and decreased gross margins on prescription services to 20%.

The Company updated the shareholders that the advanced notification period to Medicaid has elapsed as of May 12, 2019. The acquisition is on track for a hard close on June 1st, 2019 at which point FPRX, with its 2 cash flow positive Florida locations, will consolidate in the Company financial results which is projected to bring the Company to over $30 million in annual revenues for fiscal year 2019, add approximately $250,000 in net earnings, and 50 new employees under the Progressive Care umbrella. The Company will conduct an audited inventory count on the date of closing and begin releasing funds on June 3rd, 2019.

The Company announced plans to market current CBD brands and leverage the cash buying customer base to fortify against insurance rate compression and increase profitability. The Company is continuing to proceed on plans to produce an exclusive line of products that incorporates the Company's brand and mission to further develop its core market base and healthcare capabilities.

"2019 is moving at an unprecedented pace," said S. Parikh Mars, CEO of Progressive Care. "In a few short weeks, Progressive Care will double in size in almost every measurable way. We will not only be gaining sales, locations, or economies, but a wealth of talent that includes expertise in pharmaceutical logistics, operational management, and clinical awareness. We look forward to learning from this impressive group of individuals and believe that the combination of our two organizations will produce an unstoppable force."

4. Annual Shareholder Letter for 2019 Forecast and Goals – Done: Press Release 1/17/2019
Ms. Shital Mars, CEO shared the outlook for 2019 and highlights from 2018.

Progressive Care OUTLOOK
The following are our strategic goals for 2019:
• Achieve 40,000 prescriptions filled in a single month
• Increase annual same store sales to $24 million
• Close on second acquisition leading to consolidated revenue of over $35 million
• Secure additional 340B contracts and long-term care facility relationships
• Achieve accreditation for non-sterile compounding
• Achieve full enterprise profitability and earnings growth
• Install Tele-PharmCo enabled kiosks and equipment in senior living communities and large-scale clinics
• Develop exclusive line of CBD products
• Conduct PharmCo evidence-based case studies
• Release PharmCo's first televised advertisement
• Become SEC registered and fully reporting

5. CBD Manufacturer Partnership Agreement

CBD news will be OUT SHORTLY! THEIR SUPPLIERS ARE UPDATING THEIR LABELS AS REQUESTED BY FDA RIGHT NOW!
May 15, 2019 - The Company announced plans to market current CBD brands and leverage the cash buying customer base to fortify against insurance rate compression and increase profitability. The Company is continuing to proceed on plans to produce an exclusive line of products that incorporates the Company's brand and mission to further develop its core market base and healthcare capabilities.

6. Announcement of SEC Registration Completion

Progressive Care will audit the new Orlando pharmacy’s financials once the acquisition is completed. They will file SEC together. Prior to end of 2019, most likely much much sooner.

7. Progressive Care, Inc CEO Recognized by Forbes

Progressive Care, Inc CEO Recognized by Forbes as a Unique Leader

MIAMI – April 29, 2019 – InvestorsHub NewsWire -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced that it has garnered media coverage in Forbes in an article titled, A Unique Path Towards Leadership Creates a Unique Leader.

8. PharmcoRx Commerical

PharmCoRx Commercial in English and many other languages

https://youtu.be/z642uN9Ppho

9. CBS Miami Interview on “Opioid Weening”

Interviewing CEO Shital Mars, and compounding pharmacist Momina and PharmCo’s patient.

https://www.msn.com/en-us/news/us/custom-made-lotions-provide-patients-with-alternative-to-opioids/vp-BBTSnqn



10. Tele-Pharmacy Licensing Deals

We're are going to be a technology company too. If you look five years from now, CVS, Walgreens, Walmart will be using the solutions we developed and we pioneered and they're going to have to look at us for what we just like the Xerox years ago, had developed all of this tech that were then used by other people.

I don't want to be the Xerox, we're going to own that tech. We're going to be the one you have to come to if you want to advance in the technology sphere of patient management, of healthcare management, of telemedicine, of tele-pharmacy, of whatever. If you're helping a patient and healthcare happens at home, somewhere PharmCo and Progressive Care is going to be involved. So that's the future. That's what we're working toward and that's what all of our shareholders have to look forward to.

11. Progressive Care Inc. Subsidiary PharmCo, LLC Earns Top Performance Scores From Humana Inc. Press Release 02/27/2019

MIAMI, Feb. 27, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced that its wholly owned subsidiary PharmCo, LLC has met all three of the performance measures and is in the top 10% in the nation evaluated by Humana Inc., a leading health and well-being company, as part of its Rx Quality Network program. As a result of PharmCo’s performance scores for 2018, the company will receive the maximum payout offered by Humana as part of the program’s rewards.

ALL OF THIS COULD LEAD TO A SIMILAR SITUATION AS BELOW IN THE FUTURE IN TERMS OF VALUATION – AGAIN HUGE LONGTERM INVESTEMENT POTENTIAL

LOOK AT AMAZONS BUY OF PILLPACK for around $1 Billion, and PillPack revenues were $100 million. RXMD has a ton of revenues. Over $20 million net revenues for FY 2018 and has acquired 2nd location.